China Regenerative Medicine International Limited (HKG:8158)

Market Cap	121.70M
Revenue (ttm)	72.06M -20.5%
Net Income	27.53M +55.1%
EPS	0.09 +55.2%
Shares Out	304.25M
PE Ratio	4.42
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,000
Open	0.3400
Previous Close	0.4000
Day's Range	0.3350 - 0.3850
52-Week Range	0.2400 - 1.2000
Beta	-0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 27, 2026

About HKG:8158

China Regenerative Medicine International Limited, together with its subsidiaries, engages in the research, development, production, and sale of tissue engineering and regenerative medicine products in Hong Kong and China. It operates in two segments, Aesthetic Medical and Beauty Services, and Medical Services. The company offers anti-aging /prevention, functional medicine and solutions, and treatment and diagnosis; hair regenerating medical solutions; and zoom consultation, mental fog therapy, physiotherapy, acnes treatment, and facial and sli...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 30
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8158

Financial Performance

In 2025, HKG:8158's revenue was 72.06 million, a decrease of -20.48% compared to the previous year's 90.62 million. Earnings were 27.53 million, an increase of 55.05%.